COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
Autor: | Bukhari AE; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., AlDosari DA; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., AlDosari MA; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., Muqrin RF; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., Moazin OM; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., Almutlq MM; Department of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia., Altalhab SM; Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia., Alharithy RS; Department of Dermatology, Princess Nourah Bint Abdul Rahman University, Security Forces Hospital, Riyadh, Saudi Arabia., Alkhalifah AI; Department of Dermatology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of family medicine and primary care [J Family Med Prim Care] 2023 Dec; Vol. 12 (12), pp. 3304-3311. Date of Electronic Publication: 2023 Dec 21. |
DOI: | 10.4103/jfmpc.jfmpc_314_23 |
Abstrakt: | Introduction: Many cases of telogen effluvium (TE), acute hair shedding, following coronavirus disease 2019 (COVID-19) were reported during the pandemic. Methodology: We conducted a cross-sectional study to assess the relationship between COVID-19 and TE in Saudi Arabia. Self-administered online questionnaires were distributed online between March and September 2022 in Saudi Arabia. A multivariate logistic regression model was used to determine risk factors associated with TE post-COVID-19 (significance at P < 0.05). Results: Of the 703 responders, 392 were included in the study. 59.70% ( n = 234) recognized hair shedding during or after COVID-19. The time taken to realize hair shedding (3 or 6 months) and the duration varied (3, 6, >6 months). The risk factors significantly related to TE post-COVID-19 were: female sex ( P < 0.001, odds ratio [OR] = 2.98), COVID-19 antiviral treatment ( P = 0.032, OR = 3.02), and TE history ( P = 0.001, OR = 3.78). Conclusion: Healthcare providers and physicians should be aware of the relationship between TE and COVID-19, to easily recognize, treat, and improve their patients' outcomes). Competing Interests: There are no conflicts of interest. (Copyright: © 2023 Journal of Family Medicine and Primary Care.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |